Martin LA - Search Results

1

The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer.

Folkerd EJ, Martin LA, Kendall A, Dowsett M. Folkerd EJ, et al. Among authors: martin la. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):250-5. doi: 10.1016/j.jsbmb.2006.09.024. Epub 2006 Oct 17. J Steroid Biochem Mol Biol. 2006. PMID: 17049846 Review.

2

Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.

Chan CM, Martin LA, Johnston SR, Ali S, Dowsett M. Chan CM, et al. Among authors: martin la. J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):333-41. doi: 10.1016/s0960-0760(02)00074-2. J Steroid Biochem Mol Biol. 2002. PMID: 12361723

3

Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer.

Johnston SR, Head J, Pancholi S, Detre S, Martin LA, Smith IE, Dowsett M. Johnston SR, et al. Among authors: martin la. Clin Cancer Res. 2003 Jan;9(1 Pt 2):524S-32S. Clin Cancer Res. 2003. PMID: 12538510 Review.

4

Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.

Martin LA, Farmer I, Johnston SR, Ali S, Marshall C, Dowsett M. Martin LA, et al. J Biol Chem. 2003 Aug 15;278(33):30458-68. doi: 10.1074/jbc.M305226200. Epub 2003 May 29. J Biol Chem. 2003. PMID: 12775708 Free article.

5

Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer.

Davies G, Salter J, Hills M, Martin LA, Sacks N, Dowsett M. Davies G, et al. Among authors: martin la. Clin Cancer Res. 2003 Jul;9(7):2651-6. Clin Cancer Res. 2003. PMID: 12855643

6

Mechanisms of resistance to aromatase inhibitors.

Dowsett M, Martin LA, Smith I, Johnston S. Dowsett M, et al. Among authors: martin la. J Steroid Biochem Mol Biol. 2005 May;95(1-5):167-72. doi: 10.1016/j.jsbmb.2005.04.022. J Steroid Biochem Mol Biol. 2005. PMID: 15982868 Review.

7

Aromatase inhibitors: combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance.

Johnston SR, Martin LA, Head J, Smith I, Dowsett M. Johnston SR, et al. Among authors: martin la. J Steroid Biochem Mol Biol. 2005 May;95(1-5):173-81. doi: 10.1016/j.jsbmb.2005.04.004. J Steroid Biochem Mol Biol. 2005. PMID: 15996863 Review.

8

Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.

Martin LA, Farmer I, Johnston SR, Ali S, Dowsett M. Martin LA, et al. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S75-84. doi: 10.1677/erc.1.01023. Endocr Relat Cancer. 2005. PMID: 16113101

9

Life following aromatase inhibitors--where now for endocrine sequencing?

Johnston SR, Martin LA, Dowsett M. Johnston SR, et al. Among authors: martin la. Breast Cancer Res Treat. 2005;93 Suppl 1:S19-25. doi: 10.1007/s10549-005-9038-2. Breast Cancer Res Treat. 2005. PMID: 16247596 Review.

10

Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer.

Johnston SR, Martin LA, Leary A, Head J, Dowsett M. Johnston SR, et al. Among authors: martin la. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):180-6. doi: 10.1016/j.jsbmb.2007.05.019. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17624764 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters